| Ashish H Patel, AA | |
|
110 Irving St Nw, Washington, DC 20010-2976 | |
| (301) 946-5100 | |
| (301) 929-0348 |
| Full Name | Ashish H Patel |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 26 Years |
| Location | 110 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639284185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA000002 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer.
How well cancer patients fared after chemotherapy was affected by their social interaction with other patients during treatment, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
Three in four patients with refractory status epilepticus treated in an intensive care unit are still alive a year later, and half of them have recovered to baseline function, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer.
How well cancer patients fared after chemotherapy was affected by their social interaction with other patients during treatment, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
Three in four patients with refractory status epilepticus treated in an intensive care unit are still alive a year later, and half of them have recovered to baseline function, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashish H Patel, AA 11510 Georgia Ave, Suite 206, Wheaton, MD 20902-1925 Ph: (301) 946-5100 | Ashish H Patel, AA 110 Irving St Nw, Washington, DC 20010-2976 Ph: (301) 946-5100 |
News Archive
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer.
How well cancer patients fared after chemotherapy was affected by their social interaction with other patients during treatment, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
Three in four patients with refractory status epilepticus treated in an intensive care unit are still alive a year later, and half of them have recovered to baseline function, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
Alexandra Megan Fine, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Alexa Aramini, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-3303 | |
Shelby Fullen, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Domenic Derobertis, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-854-7000 | |
Timothy Olukanni, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-715-4000 | |
Kanchanish Kaur, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-9418 | |
Elizabeth Stephenson, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 |